InfuSystem (INFU) director awarded 24,890 stock options at $8.37 exercise price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
InfuSystem Holdings director Ronald T. Hundzinski received a stock option grant covering 24,890 shares of common stock. The option has an exercise price of $8.37 per share, vests on May 12, 2027, and expires on May 12, 2036. It represents a compensation-related award rather than an open-market purchase or sale. Following the reported transactions, Hundzinski holds 5,000 shares of InfuSystem common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Hundzinski Ronald T
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 24,890 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 24,890 shares (Direct, null);
Common Stock — 5,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 24,890 shares
Exercise price: $8.37 per share
Underlying shares: 24,890 shares
+3 more
6 metrics
Option grant size
24,890 shares
Stock Option (right to buy) granted to director
Exercise price
$8.37 per share
Conversion or exercise price of stock option
Underlying shares
24,890 shares
Underlying InfuSystem common stock for the option
Common shares held
5,000 shares
Total InfuSystem common stock held directly after transactions
Vesting date
May 12, 2027
Option vests on this date per footnote
Expiration date
May 12, 2036
Option expires on this date
Key Terms
Stock Option (right to buy), Grant, award, or other acquisition, Common Stock, vests, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Common Stock financial
"security_title: "Common Stock" and underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vests financial
"The option ... vests on May 12, 2027."
exercise price financial
"conversion_or_exercise_price: "8.3700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did InfuSystem (INFU) director Ronald T. Hundzinski report on this Form 4?
Ronald T. Hundzinski reported receiving a new stock option grant. The award covers 24,890 shares of InfuSystem common stock as options, reflecting equity-based compensation rather than an open-market share purchase or sale, and is recorded as a direct holding.
How many InfuSystem (INFU) stock options were granted to Ronald T. Hundzinski?
He was granted options on 24,890 shares of common stock. These options give him the right to buy InfuSystem shares in the future at a fixed exercise price, subject to the vesting schedule and expiration date disclosed in the filing.
What is the exercise price of Ronald T. Hundzinski’s InfuSystem (INFU) stock options?
The options have an exercise price of $8.37 per share. This means he can buy InfuSystem common stock at $8.37 once the options vest, regardless of the market price at that time, until the options expire.
When do Ronald T. Hundzinski’s InfuSystem (INFU) stock options vest and expire?
The option vests on May 12, 2027 and expires on May 12, 2036. Vesting on that date makes the options exercisable, while the expiration date is the last day he can use them to purchase common shares.
Is Ronald T. Hundzinski’s InfuSystem (INFU) Form 4 transaction an open-market trade?
No, the key transaction is a grant of stock options as compensation. The filing shows a derivative transaction coded as a grant or award, not a purchase or sale of shares on the open market, and includes a separate holding entry.